A Prospective Study: Sintilimab and R-CHOP in PMBCL Treatment

Clinical trial NCT06412068 · UNKNOWN

Trial details

NCT number: NCT06412068
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Mediastinal Large B Cell Lymphoma

Start date: 2024-06-01
Primary completion: 2026-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.